Moderna Hantavirus +12% Rally: Can The Surge Last?
Is the Moderna Hantavirus buzz really powering MRNA’s double-digit rally, or are traders simply chasing the next outbreak story? Maik Kemper Editor in Chief Conclusion…
Hims & Hers peptide regulation: +10.5% rally tests FDA bet
Is the latest FDA shift on peptides turning Hims & Hers into a long-term growth story or just fueling a speculative spike? Maik Kemper Editor…